Mark Ammirati
Pfizer (United States)(US)Horizon Discovery Group (United States)(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Diabetes Treatment and Management, RNA and protein synthesis mechanisms, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling
Most-Cited Works
- → Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia(2007)434 cited
- → Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules(2007)271 cited
- → Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection(1996)154 cited
- → X-ray analyses of peptide–inhibitor complexes define the structural basis of specificity for human and mouse renins(1992)140 cited
- → Human liver glycogen phosphorylase inhibitors bind at a new allosteric site(2000)126 cited
- → Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins(2020)120 cited